Toth Financial Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-8
| Closed | -$6.57K | – | 868 |
|
2023
Q1 | $6.57K | Buy |
+8
| New | +$6.57K | ﹤0.01% | 502 |
|
2022
Q3 | – | Sell |
-9
| Closed | -$5K | – | 777 |
|
2022
Q2 | $5K | Buy |
9
+4
| +80% | +$2.22K | ﹤0.01% | 514 |
|
2022
Q1 | $3K | Hold |
5
| – | – | ﹤0.01% | 591 |
|
2021
Q4 | $3K | Hold |
5
| – | – | ﹤0.01% | 613 |
|
2021
Q3 | $3K | Hold |
5
| – | – | ﹤0.01% | 617 |
|
2021
Q2 | $3K | Hold |
5
| – | – | ﹤0.01% | 554 |
|
2021
Q1 | $2K | Hold |
5
| – | – | ﹤0.01% | 596 |
|
2020
Q4 | $2K | Hold |
5
| – | – | ﹤0.01% | 540 |
|
2020
Q3 | $3K | Hold |
5
| – | – | ﹤0.01% | 451 |
|
2020
Q2 | $3K | Hold |
5
| – | – | ﹤0.01% | 440 |
|
2020
Q1 | $2K | Hold |
5
| – | – | ﹤0.01% | 383 |
|
2019
Q4 | $2K | Buy |
+5
| New | +$2K | ﹤0.01% | 421 |
|